Christoph Bock elected as EMBO Member
We are delighted to announce that Christoph Bock, Principal Investigator at CeMM, has been elected as a Member of the European Molecular Biology Organization (EMBO).
With this prestigious recognition, EMBO honors Christoph Bock for his scientific contributions at the interface of biotechnology, bioinformatics, and molecular medicine. His research combines experimental immunology and cancer biology with computational methods, including machine learning and artificial intelligence. “We develop technologies to help understand human diseases in all their complexity, and we aim to program immune cells as molecular therapies,” Christoph Bock says, describing the main focus of his work.
Founded in 1964, EMBO is an organization of more than 2,100 leading life scientists that promotes excellence in the life sciences in Europe and beyond. Election to the EMBO Membership is a lifetime honor that recognizes outstanding achievements in the life sciences and a commitment to scientific exchange and collaboration. EMBO Members are actively involved in shaping the future of science through their contributions to EMBO’s activities, including its fellowship programs, scientific meetings, and policy work.
Christoph Bock joins a distinguished community of researchers whose work has made a lasting impact on biology and medicine. His election reflects the international visibility and high scientific quality of the research conducted at CeMM.
We warmly congratulate Christoph on this well-deserved recognition!
Share this article
